Treatment of Ph-negative ALL in adolescents and young adults
Treatment of Ph-negative ALL in adolescents and young adults
The new era of ALL treatment
Safety considerations for inotuzumab in patients with relapsed/refractory ALL
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer
Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast cancer
Novel therapeutic approaches in B-progenitor ALL
Identifying cancer susceptibility genes in paediatric ALL
Defining high-risk acute lymphoblastic leukaemia
Latest concepts in frontline therapy for paediatric ALL
Improving safety for healthcare workers and patients
How can we maintain emotional safety?
Enhancing nurse education and nurse-led research